123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations
Reduced uptake of 123I- metaiodobenzylguanidine (MIBG) on cardiac gammagraphy and impaired odor identification are markers of neurodegenerative diseases with Lewy bodies (LB) as a pathological hallmark, such as idiopathic Parkinson’s disease (IPD). LRRK2 patients present with a clinical syndrome ind...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101340/ |